Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upadacitinib in Relapsing Polychondritis
NCT06873100Phase 2Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Nov 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of upadacitinib in relapsing polychondritis (RP), sponsored by Peking University People's Hospital. Started Nov 2024; status: recruiting.
02
Drugs
upadacitinib
03
Conditions
relapsing polychondritis (RP)
Beyond the preview
Go deeper on NCT06873100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06873100.